[21] Use of BPC-157 is discouraged by health authorities and it has been controlled as a prescription medicine in several jurisdictions such as New Zealand and Australia, despite not actually being available for prescription
The trade-off: patients cant easily self-inject from a vial, so this tier really only works in clinics where staff can manage the dosing or with the small fraction of patients comfortable handling a syringe
Willard, J.R., Barrow, B.M
Acknowledgments We would like to acknowledge the staff and patients involved in the study at the Department of Internal Medicine, Section for Gastroenterology, and the Department of Laboratory Medicine and Pathology at Haukeland University Hospital
This is the preferred formulation for studying pulsatile endogenous GH stimulation in the laboratory
NamKoong C, Kim MS, Jang BT, Lee YH, Cho YM, Choi HJ